Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Dedicated

- PMLiVE

Dementia research alliance to fast-track new Alzheimer’s drugs

Will see Alzheimer's Research UK partner with Cambridge, Oxford and UCL universities

- PMLiVE

FDA outlines its plans to simplify DTC ads for consumers

Hopes customer-friendly terminology will aid healthcare decisions

- PMLiVE

AstraZeneca employs Wolfram tech for liver health research

Project could produce mathematical models that can detect liver problems

EU flag

Half a million cancer patients in EU use targeted drugs

New data also shows breast and lung cancers are among the most treated in Europe

- PMLiVE

Valeant and Shire said to be evaluating potential Salix bids

Valeant currently in final stages of Provenge acquisition

Gilead Sciences

Gilead agrees price cut for Sovaldi in Germany

Same sum as agreed with French government last November

- PMLiVE

NICE issues fresh rejection for Celgene’s cancer drug Imnovid

Drugpricing watchdog says the treatment is too costly for NHS use

- PMLiVE

DNA expert: use genes to assess disease risk

Leroy Hood warns that people who opt out of genetic sequencing have their “heads in the sand”

- PMLiVE

Bayer HealthCare launches online cardiovascular tool

ProHeart Path tool calculates CV risk

- PMLiVE

Personalised cancer medicines showcased in BBC investigation

Panorama looked at cutting-edge science and the new generation of oncology drugs

- PMLiVE

RSA announces three new UK hires

New faces include Omar de Bary, Beatriz de Luis and Maria-Angeles Garcia

Sanofi reception

Generic competition for Sanofi’s Renvela hits UK market

Teva and others launch cheaper versions of the chronic kidney disease drug

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links